Side Effects Tracker Template
Systematic tracking of side effects is essential for safe peptide research. This template provides a structured format for documenting any adverse reactions, their severity, timeline, and resolution.
Key Takeaways
- Record every side effect with date, onset time, severity, duration, and resolution status.
- Use a 1-5 severity scale for consistent, comparable documentation across your entire protocol.
- Compile weekly summaries to identify trends that individual entries may not reveal.
- Use the severity-based decision framework to guide protocol adjustments.
- Systematic tracking enables data-driven decisions rather than emotional reactions.
Side Effect Entry Fields
Each side effect observation should be recorded with consistent detail. This structured entry format ensures you capture all the information needed for meaningful analysis.
- 1.Date and time of onset (how soon after injection)
- 2.Description of the effect (be specific: location, sensation, appearance)
- 3.Severity rating: 1 (barely noticeable) to 5 (severe, protocol-stopping)
- 4.Duration: how long the effect lasted before resolution
- 5.Action taken: none, reduced dose, skipped next dose, discontinued
- 6.Resolution: resolved on its own, resolved with action, ongoing
Common Side Effects to Monitor
While side effects vary by peptide, certain reactions are common across peptide research. Knowing what to watch for helps you detect issues early and document them accurately.
- 1.Injection site: redness, swelling, bruising, itching, lumps or nodules
- 2.GH-related: water retention, joint stiffness, numbness or tingling in extremities, headaches
- 3.GLP-1 related: nausea, reduced appetite (expected), constipation, headaches, fatigue
- 4.General: dizziness, fatigue, mood changes, sleep quality changes
- 5.Skin: flushing, rash, increased or decreased pigmentation
Weekly Side Effect Summary
At the end of each week, compile a summary of all side effects experienced. This provides a trend view that individual entries cannot capture and helps identify patterns related to dose timing, amount, or cumulative exposure.
- 1.Total number of side effect events this week
- 2.Most common side effect and its average severity
- 3.Any new side effects not experienced in previous weeks
- 4.Any side effects that have resolved compared to previous weeks
- 5.Overall tolerance assessment: improving, stable, or worsening
Decision Framework
Use accumulated side effect data to make protocol decisions. This framework provides guidelines for when different actions are appropriate based on side effect severity and pattern.
- 1.Severity 1-2 (mild): continue protocol, monitor for changes
- 2.Severity 3 (moderate): consider reducing dose by 25-50% and reassessing after 1 week
- 3.Severity 4 (significant): pause protocol for 3-7 days, resume at lower dose if effect resolves
- 4.Severity 5 (severe): discontinue immediately and consult a healthcare professional
- 5.Any systemic signs (fever, difficulty breathing, severe swelling): discontinue and seek medical attention immediately
Frequently Asked Questions
Should I track positive effects as well as side effects?
Yes. Tracking positive effects (improvements in the areas you are researching) alongside side effects gives you a complete picture of the risk-benefit profile. Your research log template should capture both. The side effects tracker specifically focuses on adverse reactions because they require more detailed documentation for safety decision-making.
How do I distinguish between a side effect and a coincidence?
Temporal correlation is the strongest initial indicator: did the effect start after beginning the peptide and does it recur after subsequent doses? If you stop the peptide and the effect resolves, then returns when you restart, that strongly suggests causation. Documenting timing precisely in this tracker helps identify these patterns objectively.
At what point should I see a doctor about a side effect?
Seek medical attention for any severe reaction (severity 5), any sign of infection (fever, expanding redness, pus at injection site), allergic reactions (hives, swelling, breathing difficulty), or any effect that concerns you regardless of severity. It is better to have a minor concern checked than to ignore a developing problem. Inform the healthcare provider about your research protocol for proper assessment.